GlassScriptPhysician profile
Paramjeet Gill
NPI 1033183140
$91,645.93
in general payments reported to CMS, 2019-2025
12 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $17K · 2021: $6,626 · 2022: $11K · 2023: $6,935 · 2024: $1,374 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Food and Beverage: $2,712.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Food and Beverage | $2,712.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $87,508.79 | 2019-2024 | Omnibotics 3.0, Corin Technology, Unity Cementless |
| Stryker Corporation | $2,695.84 | 2020-2025 | Mako, Insignia, Tritanium |
| Corin USA | $1,068.24 | 2019 | |
| Medtronic USA, INC. | $137.56 | 2019 | |
| Bioventus LLC | $50.21 | 2023-2025 | Xcell, Durolane |
| Ferring Pharmaceuticals INC. | $37.74 | 2022-2025 | Euflexxa |
| Ethicon US, LLC | $37.48 | 2025 | Vistaseal, Surgicel Nu-Knit, Dermabond |
| Heraeus Medical, LLC. | $30.65 | 2022-2023 | Palacos |
| Boston Scientific Corporation | $22.71 | 2023 | |
| Horizon Therapeutics Plc | $20.49 | 2021 | |
| Smith+Nephew, INC. | $20.27 | 2025 | Pico |
| Resmed Corp | $15.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paramjeet Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.